1-92833452-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000969.5(RPL5):c.67C>T(p.Arg23*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R23R) has been classified as Likely benign.
Frequency
Consequence
NM_000969.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL5 | NM_000969.5 | c.67C>T | p.Arg23* | stop_gained | Exon 2 of 8 | ENST00000370321.8 | NP_000960.2 | |
DIPK1A | NM_001252273.2 | c.475-418G>A | intron_variant | Intron 4 of 4 | NP_001239202.1 | |||
RPL5 | NR_146333.1 | n.196C>T | non_coding_transcript_exon_variant | Exon 2 of 8 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Diamond-Blackfan anemia Pathogenic:2
The p.R23* pathogenic mutation (also known as c.67C>T), located in coding exon 2 of the RPL5 gene, results from a C to T substitution at nucleotide position 67. This changes the amino acid from an arginine to a stop codon within coding exon 2. This alteration was reported to occur de novo in an individual diagnosed with Diamond-Blackfan anemia (DBA) who was also born with cleft lip and palate (Gazda HT et al. Am. J. Hum. Genet., 2008 Dec;83:769-80), and has been detected in other DBA cohorts and in a congenital heart disease cohort (Smetanina NS et al. Pediatr Blood Cancer. 2015 Sep;62(9):1597-600; Jin SC et al. Nat. Genet. 2017 Nov;49(11):1593-1601). A study of induced pluripotent stem cells derived from a patient with this mutation reported defects in ribosome biogenesis and hematopoiesis (Garçon L et al. Blood. 2013 Aug;122(6):912-21). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in RPL5 are known to be pathogenic (PMID: 19061985, 19773262). This variant has been observed in an individual affected with Diamond-Blackfan anemia (PMID: 19061985) and an individual with congenital heart disease (PMID: 28991257). ClinVar contains an entry for this variant (Variation ID: 6179). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg23*) in the RPL5 gene. It is expected to result in an absent or disrupted protein product. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23744582, 25525159, 28991257, 32368696, 33084842, 19061985) -
Diamond-Blackfan anemia 6 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at